Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
NIHNational Institutes of Health (US)
NIHNews in Health (National Institutes of Health)
NIHNot Invented Here
NIHNeointimal Hyperplasia
NIHNational Institute of Hydrology (India)
NIHNatural Infant Hygiene
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
He said that for the first time NIH has developed National Laboratory Policy, National Bio safety Policy, Case Definition Booklet and List of Priority Diseases while NIH has also drafted Public Health Act, Integrated Vector Borne Control plan and Pandemic Preparedness Plan.
However, the NIH stopped the construction work,' he said.
The NIH, through its trans-NIH Center for Regenerative Medicine (NIH CRM), the NIH Clinical Center, and the newly established NIH Center for Translational Therapeutics (NCTT), will foster these interactions.
The NIH is considering new mechanisms of direct support of drug development efforts within the small business community, but no decision has been made public at this time.
In addition, we will continue to work together to monitor and improve the peer-review process for NIEHS applications across all NIH study sections.
This is a shift in the policy spelled out by NIH in February 2005 in the wake of a series of congressional hearings that exposed a number of potential conflicts of interest by NIH scientists.
Scientists at the NIH have discovered many things over the years, but evidently they haven't yet found a way to balance innovation and objectivity.
NIH, 301-496-4000, feb2005/od-03.htm
Physicians, scientists, and other specialists on the NIH payroll will still be permitted to treat patients for fees, teach bona fide university courses, write textbooks, and receive pavement for activities related to continuing medical education.
Shortly after Zerhouni's announcement, the Office of Government Ethics, which had previously found no major problems with the NIH's consulting policies, issued a report recommending that the NIH prohibit all consulting with pharmaceutical companies.
"Although NIH has not yet completed our review and analysis of individual consulting activities, we have identified vulnerabilities in our system that give us pause," NIH deputy director Raynard S.